Table 1.

Demographic characteristics of PsA patients (n = 150).

Age (years) (mean ± SD)	45.6 ± 14.1
Male/female	88/62
Disease duration (months) (mean ± SD)	27.5 ± 18.6
Clinical manifestations
Peripheral arthritis (polyarthritis, oligoarthritis, and distal IF)	72%
Axial disease	25%
Enthesitis	47%
Dactylitis	38%
Cutaneous psoriasis	86%
Drug treatment
None	12%
NSAID	20%
Low dose steroids and/or DMARDs	48%
Anti-TNF therapy	20%

NSAID: nonsteroidal anti-inflammatory drugs; DMARDs: disease-modifying antirheumatic drugs; TNF: tumor necrosis factor.